Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Soleno Therapeutics in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst K. Kluska expects that the company ...

Soleno Therapeutics has a twelve month low of $36.61 and a twelve month high of $60.92. Soleno Therapeutics ( NASDAQ:SLNO – Get Free Report ) last posted its quarterly earnings data on Wednesday ...

In this article, we are going to take a look at where Soleno Therapeutics, Inc. (NASDAQ:SLNO) stands against other top small cap stocks to buy with the highest upside potential. What Would 2025 ...

Autolus Therapeutics (AUTL) announces an oral presentation and three poster presentations accepted to the 2025 Tandem Meetings Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR ...

Scilex (SCLX) announced that it has entered into an amendment to its existing license agreement with Romeg Therapeutics, entered into in June 2022, for ex-U.S. rights to Gloperba. Romeg had ...

Two Nebraska researchers have launched a startup company aimed at bringing to market an innovative method for delivering therapeutics, gene editing tools, plasmids and more to targeted locations in ...

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by researchers at Penn State, could eliminate the need for refrigeration for ...

MIAMI, January 16, 2025--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 145,550 shares of common ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.